Non-alcoholic steatohepatitis (NASH) is a progressive liver disease characterized by inflammation and accumulation of fat in the liver, often associated with obesity, diabetes and metabolic syndrome leading to fibrosis and ultimately cirrhosis of the liver. The literature search...
Open access
Research Article10.9734/ajmah/2024/v22i101100
Objective: This prospective case series aimed to evaluate the efficacy of saroglitazar 4 mg in improving clinical parameters in patients with type 2 diabetes mellitus (T2DM) with steatotic liver disease (SLD), focusing on glycemic control, lipid profile, liver enzymes, and transi...
Open access
Research Article10.9734/ajmah/2024/v22i91085
Kukwah Anthony Tufon, Henry Dilonga Meriki, Kwenti Emmanuel Tebit, Teuwafeu Denis Georges, Nyeke James Tony, Nicholas Tendongfor, George Enow-Orock & Damian Nota Anong·Microbiology Research Journal International·2019
Aim: HBV infection is known to cause liver fibrosis as well as some extrahepatic manifestations. We aimed at assessing hematological changes and identifying possible hepatic fibrosis of Hepatitis B origin using non-invasive markers (NIMs). Study Design: A hospital-based Case-cont...
Open access
Research Article10.9734/mrji/2018/v26i530077